Literature DB >> 16040048

PCR-RFLP genotyping for exon 1 and promoter region mutations of the human mannose binding lectin (MBL-2) gene.

S K Tin1, L Y Lee, J Thumboo, D R Koh, K Y Fong.   

Abstract

The Mannose Binding Lectin (MBL) plays an important role in innate immunity and its genetic deficiencies are associated with frequent and prolonged infections. Serum MBL determination may not accurately detect acute phase protein levels and it is also difficult to detect dysfunctional protein. Genotyping of the exon 1 and promoter regions in the MBL gene will provide useful information on the presence of deficiencies in patients. A reproducible PCR-RFLP method is described to accurately detect genotypes of exon 1 and polymorphic haplotypes of the promoter region in the MBL gene.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16040048     DOI: 10.1016/j.jim.2005.06.001

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  3 in total

1.  Mannose-binding lectin MBL2 gene polymorphisms and outcome of hepatitis C virus-infected patients.

Authors:  Eirini Koutsounaki; George N Goulielmos; Mary Koulentaki; Christianna Choulaki; Elias Kouroumalis; Emmanouil Galanakis
Journal:  J Clin Immunol       Date:  2008-07-01       Impact factor: 8.317

2.  The tumor necrosis factor α (-308 A/G) polymorphism is associated with cystic fibrosis in Mexican patients.

Authors:  Celia N Sanchez-Dominguez; Miguel A Reyes-Lopez; Adriana Bustamante; Ricardo M Cerda-Flores; Maria Del C Villalobos-Torres; Hugo L Gallardo-Blanco; Augusto Rojas-Martinez; Herminia G Martinez-Rodriguez; Hugo A Barrera-Saldaña; Rocio Ortiz-Lopez
Journal:  PLoS One       Date:  2014-03-06       Impact factor: 3.240

3.  MBL2 genotypes and their associations with MBL levels and NICU morbidity in a cohort of Greek neonates.

Authors:  Matthaios Speletas; Antonios Gounaris; Eirini Sevdali; Maria Kompoti; Katerina Konstantinidi; Rozeta Sokou; Elena Tsitsami; Anastasios E Germenis
Journal:  J Immunol Res       Date:  2015-03-24       Impact factor: 4.818

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.